[calloutleft] In this post:

  •  

    • Upcoming Appearances

    January 9, 2017: Steve Pearson, ICER’s President, will speak on improving value in drug coverage for employers at a Pacific Business Group on Health meeting in San Francisco, CA.

    January 10, 2017: Steve Pearson, ICER’s President, will participate in a panel at the JP Morgan Annual Healthcare Conference on  Access and Affordability in a New Era of Medicine.

    January 12, 2017: Dan Ollendorf, Chief Scientific Officer, will present on health system affordability to the Canadian Association of Provincial Cancer Agencies.

    January 16-17, 2017: Steve Pearson, ICER’s President,  will be a plenary speaker at the 2017 Global Haemophilia Advocacy Summit in Amsterdam

    January 18, 2017: Sarah Emond, COO, will speak at the Employers’ Forum of Indiana.

    January 29-31, 2017: Steve Pearson, ICER’s President, will present on value frameworks at the HTAi Policy Forum in Barcelona.  Dan Ollendorf, Chief Scientific Officer, will speak on input from patient groups in our value framework revision process.[wpanchor id=”dates”]

    Key Dates

    January 9th: Revised Scoping Document for osteoporosis posted

    January 18th: Draft Evidence Report on treatments for rheumatoid arthritis posted

    January 18th– February 15th: Public comment on rheumatoid arthritis report

    January 26th: Evidence Report on treatments for multiple sclerosis posted[wpanchor id=”other”]